MAPS Closes Initial Phase of Israeli MDMA/PTSD Study

In our Israeli MDMA/PTSD study, we’ve currently completed a preliminary analysis of the data. All five of the subjects enrolled to date have been treated without any evidence of harm. However, while there is some evidence of efficacy, its minimal. We’ve decided to close out this initial study and postpone new treatments until we have obtained adequate therapeutic training for members of our Israeli co-therapist team.